- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05494632
Interaural Frequency and Loudness Mismatch in SSD CI Users
Effects of Interaural Frequency and Loudness Mismatch on SSD-CI Performance
Study Overview
Status
Conditions
Intervention / Treatment
- Device: Treatment-modifications to CI speech processor program. Specifically reducing interaural frequency mismatch in experienced SSD-CI recipients.
- Device: Treatment-modifications to CI speech processor program to reduced interaural frequency mismatch in newly implanted SSD-CI recipients.
- Device: Treatment-modifications to CI speech processor program to reduced interaural loudness mismatch in experienced SSD-CI recipients.
Detailed Description
Effective binaural processing depends on similar loudness growth functions at each ear. The use of interaural level differences (ILDs), perceived as loudness differences, to locate sound is critical given the inability of cochlear implant (CI) recipients to use interaural time differences (ITDs) in binaural processing. In CI recipients with single-sided deafness (SSD), perceived interaural loudness differences may not be valid indicators of interaural level differences because the CI compresses amplitude. Studies suggest better preservation of ILDs may contribute to improved localization and understanding in noise. Since SSD-CI recipients use only one device, an approach to improve their use of ILDs is to match perceived loudness at each ear.
Binaural processing is also affected when signals of equal frequency are not matched in pitch at each ear. In bilateral CI recipients, the investigators found that the greater the pitch mismatch between ears, the poorer the speech understanding in noise. The investigators want to extend this work to SSD-CI recipients. Through CI program modifications, the study aims to decrease the pitch and loudness mismatch between the CI ear and the normal hearing ear to improve binaural listening abilities, specifically speech understanding in noise and sound localization.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants for the proposed study will be adults with single-sided deafness. Participants will have at least 6 months experience with their cochlear implant or will be newly implanted with the cochlear implant.
Inclusion criteria for the experienced CI user group and the newly implant group are as follows:
- 18 years of age and older
- Postlingual onset of SSD
- Pure tone average (PTA) at 500, 1000, and 2000 Hz of less than or equal to 30 dB HL in the contralateral ear, known as the normal hearing ear
- Implanted with or chosen to be implanted with a Nucleus cochlear implant
- Full insertion of electrode array
Exclusion Criteria:
- • Not meeting the inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Period 1: Study 1
CI speech processor programming in experienced cochlear implant (CI) recipients with single sided deafness.
Program changes were made to decrease the interaural frequency mismatch between the CI ear and the contralateral ear.
|
We will modify the CI speech processor program to reduce interaural frequency mismatch between the CI ear and the contralateral ear in experienced CI recipients with SSD.
|
|
Experimental: Period 2: Study 2
CI speech processor programming in newly implanted cochlear implant (CI) recipients with single sided deafness.
Program changes were made to decrease the interaural frequency mismatch between the CI ear and the contralateral ear.
|
We will modify the CI speech processor program to reduce interaural frequency mismatch between the CI ear and the contralateral ear in newly implanted CI recipients with SSD.
|
|
Experimental: Period 3: study 3
CI speech processor programming in experienced cochlear implant (CI) recipients with single sided deafness.
Program changes were made to decrease the interaural loudness mismatch between the CI ear and the contralateral ear.
|
We will modify the CI speech processor program to reduce interaural loudness mismatch between the CI ear and the contralateral ear in experienced CI recipients with SSD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Speech Understanding in Noise, Measured With the R-Space Test Environment. The R-Space Test Environment Simulates Speech Understanding in a Noisy Restaurant.
Time Frame: Participants were tested in the R-Space twice with each speech processor program, e.g., everyday or default program and modified program. The testing was carried out within a 2-3 month time period, and after using each program for at least 6 weeks.
|
Participants speech understanding was evaluated in the R-Space test environment with two speech processor programs, an everyday or default program and a modified program.
The modified program was created to reduce interaural frequency or loudness mismatch between participants' CI ear and normal hearing ear.
The R-Space simulates listening in a noisy restaurant, a real-world listening situation.
The score is a signal-to-noise ratio that reflects 50% speech understanding in noise.
Participants are surrounded by 8 loudspeakers with restaurant noise from all 8.
A sentence is presented from the front loudspeaker.
Participants repeat back what they hear.
The noise is adjusted adaptively.
For a correct response, the noise is increased; it is decreased for an incorrect response.
This provides signal-to-noise ratio (SNR) for 50% speech understanding.
The average score for participants with normal hearing is -5 dB SNR.
A lower number represents better performance than a higher number.
|
Participants were tested in the R-Space twice with each speech processor program, e.g., everyday or default program and modified program. The testing was carried out within a 2-3 month time period, and after using each program for at least 6 weeks.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jill B Firszt, PhD, Washington University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202206085
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Outcomes
-
Zimmer BiometActive, not recruitingClinical Outcomes | Survivorship | Safety | Functional Outcomes | Radiological OutcomesUnited States
-
Third Military Medical UniversityCompletedPerioperative Outcomes | Oncological OutcomesChina
-
University of LiegeCompletedIntraoperative Outcomes | Postoperative Outcomes
-
ModernaTX, Inc.CompletedPregnancy | Maternal Outcomes | Infant OutcomesUnited States
-
G. d'Annunzio UniversitySan Giovanni di Dio HospitalActive, not recruitingCearean Section Rate | Maternal Adverse Outcomes | Neonatal Adverse OutcomesItaly
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPregnancy | Food Insecurity | Birth Outcomes | Livelihood Interventions | Infant Health OutcomesKenya
-
Peking Union Medical College HospitalUnknown
-
Yibelu Bazezew BitewaCompletedPerinatal Outcomes | Maternal Outcomes | Maternity Continuum of Care | Obstetric Health LiteracyEthiopia
-
University of OklahomaNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
Malihe MahmoudiniaNot yet recruiting